+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Market Spotlight: Gout - Product Thumbnail Image

Market Spotlight: Gout

  • Report
  • January 2021
  • 38 Pages
  • Global
From
From
Autoimmune Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Autoimmune Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 78 Pages
  • China
From
Arthritis Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Arthritis Treatment Drugs Industry Forecasts - China Focus

  • Report
  • August 2024
  • 104 Pages
  • China
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more